"L’Hôpital Le Corbusier assure une prise en charge pluridisciplinaire médicale et chirurgicale sur son territoire. Il dispose d’une infrastructure médico-technique performante : scanner, radiologie numérisée, angio-coronarographie, plateau technique opératoire, chirurgie ambulatoire, salles de naissance, endoscopie digestive, laboratoire de biologie, pharmacie à usage intérieur, stérilisation centrale. Au sein de la région Rhône-Alpes-Auvergne, l’Hôpital Le Corbusier accueille et soigne la population du bassin de Firminy, de la vallée de l’Ondaine et de la Haute-Loire jusqu’à l’Yssingelais."

During the past decade, CH de Firminy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Firminy" #1 collaborator was "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Ministry of Health, France" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "CH de Firminy" are "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Arrhythmia" (1 trials), "Atrial Flutter" (1 trials) and "Atrial Tachycardia" (1 trials). Many other conditions were trialed in "CH de Firminy" in a lesser frequency.

Most popular intervention types in "CH de Firminy" are "Other" (4 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Advice and recommendations of physical activity at home" (1 trials), "Telecardiology" (1 trials), "consultation with a vascular physician" (1 trials), "period with drug (trade name) then period with generic" (1 trials) and "period with generic then period with drug (trade name)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH de Firminy" are 8 trials for "All" genders.

Currently, there are NaN active trials in "CH de Firminy". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in CH de Firminy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH de Firminy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".